- Allengers Medical Systems Limited
- Hologic, Inc.
- FUJIFILM Holdings America Corporation
- PLANMED OY
- GENERAL ELECTRIC
- Konica Minolta, Inc.
- Siemens Healthcare Private Limited
- Carestream Health
- GE Healthcare
- Koninklijke Philips N.V.
- BET Medical
(Note: The list of the major players will be updated with the latest market scenario and trends)
Recent developments by key players in Mammography Market:
In May 2022- At the SBI/ACR Breast Imaging Symposium 2022, Volpara Health showcased modified products for its comprehensive platform for the delivery of individualized breast care. Mammography quality and reporting, volumetric breast density measurements, and cancer risk assessment are all provided by Volpara's AI-driven breast software solutions.
Mammography and other breast cancer diagnostic methods are in greater demand due to the rising incidence of breast cancer worldwide. For instance, the American Cancer Society projects that in 2022, there will be 51,400 new cases of non-invasive breast cancer. Many mammography techniques or procedures, such as breast tomosynthesis, film screen systems, and X-rays, are employed for the early identification of breast cancer. Film-screen systems or screen-film mammography remain the gold standard for early breast cancer diagnosis. Factors including aging populations, hormone imbalances, and women's increased awareness of breast cancer and its diagnosis and treatment will continue to raise demand for mammography. Moreover, one of the crucial factors projected to drive demand during the forecast period is mammary gland calcification, which is encouraged by the National Breast Cancer Foundation, CDC, and Breast Cancer Organisation, among other significant organizations. The creation of 3-D imaging options (breast tomosynthesis) and other technological developments in mammography systems, as well as advances in the number of hospitals, diagnostic facilities, and specialty centers, are anticipated to speed up the market's expansion. However, the risk of radiation exposure, high initial expenses, and a general lack of awareness about mammography technologies in many developing nations hinder the market growth.